International Mesothelioma Interest Group Young Investigator Awards Recipient Hannah Moody
Kazan Law is delighted to announce that Hull York Medical School researcher Hannah Moody of the United Kingdom has been named a International Mesothelioma Interest Group Young Investigator Awards recipient for 2016. Hannah and her team concentrate their research on malignant pleural mesothelioma. Malignant pleural mesothelioma is a devastating form of a cancer that attacks the area surrounding the lungs. Ms Moody is primarily interested in unlocking the mystery behind why malignant pleural mesothelioma is so resistant to chemotherapeutics. Chemotherapeutic procedures make up a large part of the treatment for malignant pleural mesothelioma.
One key to Hannah’s research is the investigation into microRNA which are tiny molecules associated with other types of cancers. During experimentation, the team has found one type of microRNA that is able to at least partially regulate how much chemotherapy actually gets into mesothelioma cells. Hannah believes this might be a reason that could explain why the mesothelioma cells are so resistant to chemotherapeutic treatments.
International Mesothelioma Interest Group Young Investigator Awards
Co-created and funded by our sponsors Kazan Law, the Young Investigator Awards recognize the top young research scientists and doctors who are dedicating their work to discover new treatment options for mesothelioma victims. Selected every two years during the International Mesothelioma Interest Group Conference, the Young Investigator Awards provide a forum for researchers to share their findings, learn from colleagues, and raise awareness of the global fight against mesothelioma cancers.